Drug Addiction: Clinical Trials

57 trials for Drug Addiction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 4 unknown, 3 recruiting, 2 withdrawn. 27 Not applicable, 6 Phase 2, 5 Phase 3, 4 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 23, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1
Phase 26Completed 6
Phase 35Completed 5
Phase 14Completed 3, Withdrawn 1
Phase 43Completed 3
Early Phase 11Completed 1

Follow Drug Addiction: new trials by email Literature Review of Drug Addiction trials Research Report on Drug Addiction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mapping And Preventing Relapse Risk in Polydrug Users
Mindfullness based Sobriety (MBS) - Drug Addiction, Polysubstance Addiction
Not applicableCompletedInstitute of Psychology, Chinese Academy of Sciences1302025-06-242025-09-09
The Health of Women Monitored in the Addiction Department of the Strasbourg University Hospitals
Drug Addiction
RecruitingUniversity Hospital, Strasbourg, France552025-03-242025-06-24
Project on tDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals
Transcranial direct current stimulation - Drug Addiction
Not applicableEnrolling by invitationShaanxi Normal University842025-03-192025-03-21
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
life skills primary prevention - Well Being, Drug Addiction
Not applicableActive not recruitingAgenzia di Tutela della Salute della Città Metropolitana di Milano39272024-12-012026-10-05
Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD
Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME), Control - Opioid Use Disorder, Pregnancy Related
Not applicableCompletedT. John Winhusen, PhD1312024-06-132025-05-11
The Cognitive Neural Mechanisms and Neuroregulatory Interventions of Realistic Creative Problem-solving Under the Effects of Drug Addiction
Transcranial direct current stimulation - Drug Addiction
Not applicableCompletedYifan Wang802023-11-232025-04-08
Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents
Questionnaires - Drug Addiction
UnknownWei XIA, PhD2002023-07-172023-07-24
Importance of Drug User Detection
Drug Addiction
UnknownAssiut University2002023-05-012023-04-07
Relationship of Addictions to Obesity, Physical Activity and Vascular Ageing in Young Adults
Drug Addiction, Technology Addiction
UnknownFundacion para la Investigacion y Formacion en Ciencias de la Salud5002023-04-172023-05-19
Long-Term Treatment of Opioid Use Disorder
Employment-based abstinence reinforcement - Drug Addiction, Employment
Not applicableRecruitingNorthern Michigan University2252023-03-012025-05-02
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction
CompletedT. John Winhusen, PhD712021-06-142026-03-16
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction
CompletedT. John Winhusen, PhD972020-07-212026-03-16
Medication Treatment for Opioid Use Disorder in Expectant Mothers
Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction
Phase 3CompletedT. John Winhusen, PhD1402020-07-212026-06-04
Westlake Personalized Nutrition and Health Cohort for Drug Addicts
Drug Addiction, Undernutrition
CompletedWestlake University2282019-10-282021-04-14
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
Opioid-Related Disorders, Drug Addiction
RecruitingNational Institute on Drug Abuse (NIDA)1502019-06-072026-10-26
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
Treatment A with device Clickotine® (Active intervention), Treatment B with smoking education (control) - Nicotine Addiction, Drug Addiction
Not applicableWithdrawnClick Therapeutics, Inc.2018-10-252022-07-01
Innovative Digital Therapeutic for Smoking Cessation
CT-101-M, QuitGuide - Smoking Cessation, Nicotine Addiction
Not applicableCompletedMy Digital Study1582018-10-242022-06-06
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
Treatment as Usual (TAU), TAU+CBT4CBT - Substance Use Disorders, Drug Abuse
Not applicableCompletedVirginia Commonwealth University632018-10-042020-02-05
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing
self-administered, e-health application - Opioid-Related Disorders, Opioid-use Disorder
Not applicableCompletedUniversity of Cincinnati402017-11-082019-04-10
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
self-administered, e-health application - Opioid-use Disorder, IV Drug Usage
Not applicableCompletedUniversity of Cincinnati242017-11-082019-04-10

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Substance-Related Disorders (57)  ·  Opioid-Related Disorders (12)  ·  Behavior, Addictive (6)  ·  Smoking (5)  ·  Alcoholism (4)  ·  Neonatal Abstinence Syndrome (4)  ·  Tobacco Smoking (4)  ·  Tobacco Use Disorder (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Drug Overdose (3)  ·  Hepatitis C (3)  ·  Cigarette Smoking (2)  ·  Cocaine-Related Disorders (2)  ·  HIV Infections (2)  ·  Marijuana Abuse (2)

Broader conditions

Chemically-Induced Disorders (57)  ·  Mental Disorders (55)  ·  Behavior (17)  ·  Narcotic-Related Disorders (12)  ·  Compulsive Behavior (7)  ·  Impulsive Behavior (7)  ·  Communicable Diseases (6)  ·  Infections (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Blood-Borne Infections (5)  ·  RNA Virus Infections (5)  ·  Virus Diseases (5)  ·  Alcohol-Related Disorders (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genital Diseases (4)

Interventions

Transcranial Direct Current Stimulation (4)  ·  Buprenorphine (3)  ·  Buprenorphine, Naloxone Drug Combination (3)  ·  Nicotine (2)  ·  Therapeutics (2)  ·  Atrial Natriuretic Factor (1)  ·  Cannabidiol (1)  ·  Counseling (1)  ·  Creatine (1)  ·  Dosage Forms (1)  ·  Educational Status (1)  ·  Health Promotion (1)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Naloxone (1)  ·  Oxytocin (1)

Sponsors

National Institute on Drug Abuse (NIDA) (5)  ·  T. John Winhusen, PhD (4)  ·  Treatment Research Institute (4)  ·  University of Cincinnati (4)  ·  Johns Hopkins University (3)  ·  University of California, Los Angeles (3)  ·  University of Chicago (3)  ·  Click Therapeutics, Inc. (2)  ·  Federal University of Espirito Santo (2)  ·  Virginia Commonwealth University (2)  ·  Yale University (2)  ·  Agenzia di Tutela della Salute della Città Metropolitana di Milano (1)  ·  Assiut University (1)  ·  Centre for Addiction and Mental Health (1)  ·  Charite University, Berlin, Germany (1)

Countries

United States (36)  ·  China (4)  ·  Brazil (2)  ·  Canada (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Senegal (1)  ·  South Africa (1)  ·  Spain (1)

Top investigators

T. John Winhusen, PhD (4)  ·  Theresa Winhusen, PhD (4)  ·  Adeline Nyamathi, PhD (2)  ·  Ester MN Palacios, MD, PhD (2)  ·  Harriet de Wit, PhD (2)  ·  Brenda M Booth, Ph.D. (1)  ·  Brian M Iacoviello, PhD (1)  ·  Carol Myers, Ph.D. (1)  ·  Christopher J Cutter, Ph.D. (1)  ·  Colleen A Hanlon, PhD (1)  ·  Dace Svikis Pickens, PhD (1)  ·  David Farabee, Ph.D. (1)  ·  David S Festinger, Ph.D. (1)  ·  Doaa Mohamed Almaz, lecturer (1)  ·  Elliot Stein, Ph.D. (1)

Results publications

PMID 37023858, PMID 12540795, PMID 21410418, PMID 21767252, PMID 22221277, PMID 22867295, PMID 23155727, PMID 23157895, PMID 24188797, PMID 25932697, PMID 26957103, PMID 27004905, PMID 27124254, PMID 28442453, PMID 28782982, PMID 29095374, PMID 29776789, PMID 30018558, PMID 30405414, PMID 30532612, PMID 30797384, PMID 31452601, PMID 34236298, PMID 38145229, PMID 39105509, PMID 40643178, PMID 41015387, PMID 41429292, PMID 41837971

NIH funding

UG1DA013732 (4), P50DA027841 (2), 1RC1DA028467-01 (1), R01DA002812 (1), R01DA011082 (1), R01DA013496 (1), R01DA014979 (1), R01DA018208 (1), R01DA018696 (1), R01DA021621 (1), R01DA053218 (1), R21DA017885 (1), R21DA026570 (1), R34DA040862 (1), U01DA031784 (1)